| Developers: | WhiteSwell |
| Date of the premiere of the system: | January, 2021 |
| Branches: | Pharmaceutics, medicine, health care |
2021: The announcement of WhiteSwell - a kateterny system for treatment of an acute heart failure
At the end of January, 2021 the Irish company WhiteSwell provided a kateterny system for treatment of the sharp dekompensirovanny heart failure (SDHF). The latest technology consists of a catheter with the bladed pump which is intended for stimulation of a lymphatic drainage which reduces puffiness without use of diuretics.
At patients with ODSN breath is complicated, the fatigue develops and there are expressed hypostases, both external, and internal, the most dangerous of which is the pulmonary edema. ODSN requires immediate treatment in the form of removal of excesses of liquid. However not all patients well respond to therapy with diuretics, and the excessive diuresis can lead to hypotonia and deterioration in function of kidneys. WhiteSwell claims that the new technology is capable to help patients completely and to get rid quickly of developments of stagnation, protecting kidneys from by-effects of diuretics.
Developers of a drainage system note that for disposal of hypostases the excess of liquid in an interstition needs to be moved to vascular space at first. At the healthy person this function is performed by massive drainage network of lymphatic system which actively takes away liquid in trunk veins. However patients with ODSN in trunk veins can have high pressure and be slow or even to stop a flow of lymphatic liquid.
The catheter of WhiteSwell creates area of low pressure in that place of a vascular bed where the biggest lymphatic vessel, the chest channel, connects to a venous system. Thereby a system promotes the strengthened outflow of a lymph and allows to eliminate developments of stagnation in an interstition. Developers consider that application of a new catheter in a combination with diuretics can remove completely hypostasis at most of patients for shorter terms, than monotherapy by diuretics.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |